The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Is Advancing With Support From Rising Burden Of Cardiovascular Diseases Fueling The Growth Of The Market Amid Increasing Unhealthy Dietary Habits
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Rise In Market Size Of The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market During The Forecast Period?
The artificial intelligence (AI)-powered chronic heart failure digital coach market has seen substantial growth in its size recently. Projections indicate it will expand from $1.93 billion in 2025 to $2.48 billion in 2026, showing a compound annual growth rate (CAGR) of 28.3%. This past growth is largely due to the escalating incidence of heart failure, the wider acceptance of remote patient monitoring, increasing digitization in healthcare, the greater availability of connected medical devices, and a heightened emphasis on preventive cardiac care.
The artificial intelligence (AI)-powered chronic heart failure digital coach market size is anticipated to undergo significant expansion over the next few years. It is projected to climb to $6.64 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 28.0%. This growth during the forecast period is fueled by advancements in AI-powered clinical analytics, the increasing uptake of personalized care management, the broadening reach of home-based cardiac monitoring, rising investments in digital cardiology platforms, and the escalating demand for continuous patient engagement solutions. Prominent trends for the upcoming period involve the expanding deployment of AI-based cardiac monitoring coaches, greater integration with wearable heart sensors, the surging application of predictive health analytics, the enlargement of remote chronic care platforms, and a heightened focus on patient self-management tools.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28927&type=smp
Which Drivers Are Advancing The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Growth?
The escalating burden of cardiovascular diseases is anticipated to foster the expansion of the artificial intelligence (AI)-powered chronic heart failure digital coach market moving forward. Cardiovascular diseases are defined as a collection of conditions affecting the heart and blood vessels, including but not limited to coronary heart disease, cerebrovascular disease, and other disorders of the circulatory system. The prevalence of these conditions is increasing, largely because diets high in processed foods and salt lead to elevated blood pressure and cholesterol, subsequently raising the danger of heart disease. An AI-powered chronic heart failure digital coach plays a crucial role in managing cardiovascular diseases by providing real-time health monitoring and personalized recommendations concerning medications and lifestyle choices, while also facilitating early detection of complications and proactive care. For example, in October 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, indicated that 919,032 people in the United States died from cardiovascular disease in 2023, which constituted approximately one in every three deaths nationwide. Hence, the increasing impact of cardiovascular diseases is driving the growth of the artificial intelligence (AI)-powered chronic heart failure digital coach market.
Which Segment Divisions Form The Structure Of The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
The artificial intelligence (AI)-powered chronic heart failure digital coach market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Remote Patient Monitoring, Personalized Care Management, Medication Adherence, Patient Education, Other Applications
4) By End-User: Hospitals And Clinics, Homecare Settings, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Software: Cloud-Based Platforms, Mobile Applications, Data Analytics Tools, Patient Monitoring Dashboards, Integration Middleware
2) By Hardware: Wearable Devices, Smart Sensors, Connected Medical Devices, Home Monitoring Equipment, Edge Computing Devices
3) By Services: Implementation And Integration Services, Consulting Services, Maintenance And Support Services, Training And Education Services, Remote Patient Monitoring Services
What Trends Are Influencing The Future Of The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
Major companies within the artificial intelligence (AI)-powered chronic heart failure digital coach market are concentrating on developing at-home monitoring solutions, such as non-invasive platforms for heart failure management, to enhance medication adherence and enable proactive disease oversight. These non-invasive heart failure management platforms are digital systems that track heart function and patient vitals without surgery, utilizing sensors, wearables, and AI analytics to monitor symptoms and guide therapy for early intervention and improved disease management. For instance, in September 2024, Astellas Pharma Inc., a Japan-based pharmaceutical company, launched DIGITIVA, a new non-invasive digital health solution for heart failure management, with its Food and Drug Administration (FDA) listing. It facilitates at-home disease monitoring and is designed to place patients at the center of their care, combining the CORE 500 Digital Stethoscope, a smartphone app built on Welldoc’s platform, educational content from the American Heart Association, and a dedicated clinical review team to help intervene early and improve clinical outcomes, such as reducing acute events and hospitalizations.
Which Key Players Are Active In The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
Major companies operating in the artificial intelligence (AI)-powered chronic heart failure digital coach market are Koninklijke Philips N.V., Boston Scientific Corporation, Astellas Pharma Inc., Best Buy Health Inc., Tempus AI Inc., Biofourmis Inc., Athelas Inc., Hello Heart Inc., Huma Therapeutics Limited, Welldoc Inc., Cleerly Inc., Cadence Solutions Inc., Lark Health Inc., One Drop, Binah.ai Ltd., Xealth Inc., Nanowear Inc., Cordio Medical Ltd., Kento Health Inc., my mhealth Limited, Implicity SAS.
Access The Complete Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report:
Which Region Stands As The Largest Contributor To The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
North America was the largest region in the artificial intelligence (AI)-powered chronic heart failure digital coach market in 2025. The regions covered in the artificial intelligence (AI)-powered chronic heart failure digital coach market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=28927&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market 2026, By The Business Research Company
Cardiac Ai Monitoring And Diagnostics Global Market Report 2026
Ai In Medical Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report
Artificial Intelligence Ai Studio Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
